Swiss MedTech 2024

Harnessing Market Dynamics for Profitability

Wednesday, September 4, 2024
Followed by a networking drinks reception

Farelhaus|Oberer Quai 12|2503 Biel
 
 
 

AGENDA
 

Registration from 1:30 p.m.
 
 

2:00 p.m. – 2:10 p.m.
 

WELCOME 

Eva von Mühlenen, Senior Advisor, Sidley, Geneva

Sandra Item, Co-CEO of Integrated Scientific Services AG, Biel

Daniel Delfosse, Head of Regulation and Innovation,
Member of the Executive Board, Swiss Medtech
 
 

PART I: ESG
Competitive Advantages Through Early Implementation of ESG Guidelines
 
 

2:10 p.m. – 2:30 p.m.

Host: Bernhard Bichsel, Co-CEO, Integrated Scientific Services (ISS)
 

GREEN CLAIMS AND GREENWASHING: EU REQUIREMENTS AND SWISS COMMISSION FOR FAIR ADVERTISING GUIDELINE

Anna-Shari Melin, Senior Managing Associate, Sidley

Stella Perantakou, Associate, Sidley
 

2:30 p.m. – 3:10 p.m.

Host: Bernhard Bichsel, Co-CEO, Integrated Scientific Services (ISS)
 

STAYING AHEAD: INTEGRATING ESG PRINCIPLES IN THE MEDTECH INDUSTRY

Iliyana Popova, Legal Counsel EMEA, Intuitive Surgical

Laura Rabbath, Corporate Social Responsibility Manager, MPS Micro Precision Systems AG
 
 

PART II: AI
AI in MedTech: Dual Impact on Medical Devices and Operational Profitability Costs
 
 

3:10 p.m. – 3:50 p.m.

Host: Eva von Mühlenen, Senior Advisor, Sidley, Geneva
 

MACHINE LEARNING APPLICATIONS AT SWISSMEDIC 

Nicolas Löffler-Perez, Data Scientist, Swissmedic

THE VALUE OF AI FOR CLINICAL TRIALS

Poorya Amini, CEO, Risklick AG 
 

3:50 p.m. – 4:20 p.m.

Host: Eva von Mühlenen, Advisor, Sidley, Geneva
 

FUTURE HORIZONS: GLOBAL REGULATORY DEVELOPMENTS AND STRATEGIC CONSIDERATIONS

Marco Caproni, Senior Product Specialist, TÜV SÜD

Flavio Angei, Regulatory Affairs Manager Digital Products, Roche Diagnostics
 

4:20 p.m. – 4:40 p.m.
 

COFFEE BREAK
 
 

PART III: Health Data
Advancements in Switzerland: Opportunities to Harness Health Data
 
 

4:40 p.m. – 5:00 p.m.

Host: Bernhard Bichsel, Co-CEO, Integrated Scientific Services (ISS)
 

HEALTH DATA AND THE VALUE FOR PATIENTS

Judith Safford, Director, SCQM and Founder RheumaCura
 
 

PART IV: Swiss Medical Devices Regulation at a Crossroads:
FDA, EU CE – or Best of Both Worlds?
 
 

5:00 p.m. – 5:45 p.m.

Host: Andreas Balsiger Betts, Senior Advisor, Sidley, Geneva
 

Effy Vayena, Associate Vice President for Digital Transformation and Governance, ETH Zurich

Lukas Bruhin, President of the Institute Council, Swissmedic

Michael Friedrich, CEO, Distalmotion 
 

 5:45 p.m.
 

WRAP UP / GOODBYE / WHEN DO WE MEET AGAIN?

Eva von Mühlenen, Senior Advisor, Sidley, Geneva

Sandra Item, Co-CEO of Integrated Scientific Services AG, Biel

Daniel Delfosse, Head of Regulation and Innovation, Member of the Executive Board, Swiss Medtech, Bern
 

5:55 p.m. – 7:00 p.m.
 

NETWORKING / DRINKS RECEPTION